Shares of Extendicare Inc. (TSE:EXE – Get Free Report) have received an average recommendation of “Moderate Buy” from the five brokerages that are presently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation, one has given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is C$14.15.
A number of analysts have recently commented on the stock. TD Securities boosted their price objective on shares of Extendicare from C$13.00 to C$15.00 and gave the stock a “hold” rating in a research report on Thursday, May 22nd. BMO Capital Markets upped their price objective on shares of Extendicare from C$13.50 to C$14.50 in a report on Monday, May 12th. National Bank Financial raised shares of Extendicare to a “strong-buy” rating in a research report on Wednesday, July 16th. Finally, National Bankshares upped their price objective on shares of Extendicare from C$15.45 to C$16.10 and gave the stock an “outperform” rating in a research report on Friday, August 8th.
Read Our Latest Analysis on EXE
Extendicare Stock Up 0.1%
Extendicare Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 29th will be given a $0.042 dividend. This represents a $0.17 annualized dividend and a yield of 1.2%. Extendicare’s payout ratio is currently 61.20%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- What is a Microcap Stock? Everything You Need to Know
- How Did Peter Thiel-Backed Crypto Exchange Bullish’s IPO Go?
- 3 REITs to Buy and Hold for the Long Term
- Mercury Systems Up 27%: Financials Send Investors a Clear Signal
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Deereās Sell-Off Could Be a Long-Term Buying Chance
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.